These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2144390)

  • 21. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An economic assessment of pre-vaccination screening for hepatitis A and B.
    Jacobs RJ; Saab S; Meyerhoff AS; Koff RS
    Public Health Rep; 2003; 118(6):550-8. PubMed ID: 14563912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immune prophylaxis against hepatitis B virus].
    Westh H
    Ugeskr Laeger; 1989 Oct; 151(43):2784-7. PubMed ID: 2531485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New immunization initiatives and progress toward the global control of hepatitis B.
    Kane MA; Brooks A
    Curr Opin Infect Dis; 2002 Oct; 15(5):465-9. PubMed ID: 12686877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dose of hepatitis B vaccine.
    Seville P
    N Z Med J; 1988 Nov; 101(857):774. PubMed ID: 2972946
    [No Abstract]   [Full Text] [Related]  

  • 26. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).
    Coursaget P; Yvonnet B; Chotard J; Sarr M; Vincelot P; N'doye R; Diop-Mar I; Chiron JP
    Lancet; 1986 Nov; 2(8516):1143-5. PubMed ID: 2877284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of minimal doses of an American hepatitis B vaccine in neonates.
    Scaravelli C; Bianchi E; Biraghi V; Mariani G; Calligari GC; Lucchesi P; De Leo G
    Clin Ther; 1985; 7(6):680-3. PubMed ID: 2934134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination against hepatitis B in children and adolescent patients on dialysis.
    Drachman R; Isacsohn M; Rudensky B; Drukker A
    Nephrol Dial Transplant; 1989; 4(5):372-4. PubMed ID: 2528085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route.
    Carrilho FJ; Queiroz ML; da Silva LC; da Fonseca LE; Granato C; Oba I; Obara L
    Rev Inst Med Trop Sao Paulo; 1989; 31(2):91-4. PubMed ID: 2602806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to hepatitis B virus among South African health care workers--implications for pre-immunisation screening.
    Schoub BD; Johnson S; McAnerney J; Blackburn NK; Padayachee GN
    S Afr Med J; 1991 Jan; 79(1):27-9. PubMed ID: 1824730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccine.
    N Engl J Med; 1987 Jan; 316(1):47-9. PubMed ID: 2946954
    [No Abstract]   [Full Text] [Related]  

  • 33. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
    Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
    Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B vaccine set for introduction into national immunization programs.
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):372. PubMed ID: 1535642
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of hepatitis A/B vaccination in the private sector.
    Jacobs RJ; Meyerhoff AS
    Sex Transm Dis; 2005 Aug; 32(8):465. PubMed ID: 16041246
    [No Abstract]   [Full Text] [Related]  

  • 37. Intradermal, low dose, short course hepatitis B vaccination.
    Goldwater PN; Woodfield DG; Ramirez AM; Anzimlt IS
    N Z Med J; 1986 Sep; 99(810):703-5. PubMed ID: 2950344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
    Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H
    Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.